ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Chemoprevention of Cutaneous Squamous Cell Carcinoma in Renal Transplant Recipients: A Case-Controlled Analysis.

    R. Anand, R. Hung, S. Frame, K. Bramham, M. Wain, A. Cronin.

    Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.

    Organ transplant recipients are up to 200 times more likely to develop cutaneous squamous cell carcinoma (SCC) than age-matched general populations. Systemic retinoids, such as…
  • 2016 American Transplant Congress

    Transplants without Borders – A Project for In Locus Training of New Transplants Centers in Brazil.

    M. Perosa,1 J. Branez,1 L. Mota,1 B. Zeballos,1 H. Noujaim,1 L. Ianhez,1 L. Alvim,1 D. Machado,1 M. Moreno,1 T. Genzini,1 R. Kandaswamy.2

    1Transplant Department, Bandeirantes Hospital, Sao Paulo, SP, Brazil; 2Transplant, Univ Minnesota, Minneapolis, MN.

    The regional disparity in transplant activity is a huge problem in Brazil and in other countries. Brazilian transplant centers are concentrated in the coastal states,…
  • 2016 American Transplant Congress

    Advantages of Computerized Dosing Strategy in Tacrolimus Treatment of Renal Transplant Patients.

    S.-Y. Kim,1 S. Cho,1 M.-J. Cho,1 C. Lee,1 A. Han,1 C. Choi,1 S. Ahn,1 S.-I. Min,1 S.-K. Min,1 M. Park,2 I. Jung,3 S. Kim,4 J. Ha.1,2

    1Department of Surgery, Seoul National University Hospital, Seoul, Korea; 2Korea Organ Donation Agency, Seoul, Korea; 3Department of surgery, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea; 4Department of Surgery, Myoungji Hospital, Goyang-si, Korea.

    Purpose: Tacrolimus (Tac) is widely used in immunosuppression for kidney transplant (KT) patients. Despite this, it is still difficult for expert physicians to achieve and…
  • 2016 American Transplant Congress

    Original KDRI Predicts Kidney Graft Failure in a Brazilian Cohort.

    J. Reusing Jr.,1 C. Nihei,1 A. Lino de Souza,2 E. David-Neto,1 C. Ventura.3

    1Kidney Transplant Unit, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, SP, Brazil; 2Psychobiology Department, Universidade Federal de São Paulo, São Paulo, SP, Brazil; 3Renal Transplant Unit, Hospital das Clinicas of the University of Sao Paulo Medical School, São Paulo, SP, Brazil.

    Current US allocation system for kidney transplantation (KT) is based on KDRI (Kidney Donor Risk Index). In Brazil, it is still based on HLA-compatibility; donor…
  • 2016 American Transplant Congress

    Alkaline Phosphatase a New Marker for Graft Outcome and High Pulse Wave Velocity in Renal Transplant Recipients.

    S. Sezer,1 E. Tutal,1 Z. Bal,1 B. Demirci,1 M. Haberal.2

    1Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey; 2General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.

    Purpose: Alkaline phosphatase (ALP) is a marker of bone turnover which is widely used for estimating type of bone turnover in patients with end-stage renal…
  • 2016 American Transplant Congress

    Clinical Significance of C3d Binding Donor Specific Anti-HLA Antibodies (DSA) Detected by Single Antigen Beads (SAB) After Kidney Transplantation.

    R. Pelletier,1 I. Balazs,2 P. Adams,3 P. Steller,3 N. DiPaola,4 L. Rankin,3 A. Diez,5 M. Henry.1

    1Surgery/Transplant, The Ohio State University Wexner Medical Center, Columbus, OH; 2Discovery Research, Immucor, Inc, Stamford, CT; 3Tissue Typing Laboratory, The Ohio State University Wexner Medical Center, Columbus, OH; 4Methodist Hospital, Houston, TX; 5Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH.

    A new Luminex-based SAB method detects DSA compliment fixing via C3d-binding. This study compares the clinical outcomes in kidney recipients that developed de novo DSA…
  • 2016 American Transplant Congress

    Kidney Transplant Induction Therapies: Risks of Death, Allograft Failure, Sepsis, and Cancer.

    N. Koyawala,1 J. Silber,2 P. Rosenbaum,1 R. Bloom,1 W. Wang,2 A. Hill,2 S. Nazarian,1 D. Sawinski,1 J. Trofe,1 M. Lim,1 J. Schold,3 P. Reese.1

    1University of Pennsylvania, Philadelphia; 2The Children's Hospital of Philadelphia, Philadelphia; 3Cleveland Clinic, Cleveland.

    Induction therapies are commonly used during kidney transplantation (~85% of transplants in 2012). Existing studies of induction therapy are limited by short follow-up and/or absence…
  • 2016 American Transplant Congress

    Impact of the New Kidney Allocation System on Highly Sensitized Patients: Single Center Report.

    A. Mattiazzi,1 W. Kupin,1 D. Roth,1 L. Chen,2 G. Burke,2 G. Ciancio,2 P. Ruiz,2 R. Vianna,2 G. Guerra.1

    1Department of Medicine, Division of Nephrology, Miami Transplant Institute, Miami, FL; 2Department of Surgery, Miami Transplant Institute, Miami, FL.

    Background: Highly sensitized patients (HSP) with calculated Panel Reactive Antibody (cPRA) >80% are known to have extensive waiting time on UNOS list. The new kidney…
  • 2016 American Transplant Congress

    Clinical Outcomes of Kidney Allograft Recipients with Apolipoprotein L1 (APOL1) Risk Alleles from Living Kidney Donors.

    C. Dorr,1,2,3 A. Hart,1,2,3 D. Schladt,1 A. Muthusamy,1 R. Mannon,4 W. Oetting,2 A. Matas,2 P. Jacobson,2 A. Israni.1,2,3

    1Minneapolis Medical Research Foundation, Minneapolis; 2University of Minnesota, Minneapolis; 3Hennepin County Medical Center, Minneapolis; 4University of Alabama, Birmingham.

    Background:Apolipoprotein L1 (APOL1) alleles G1 and G2 in deceased donors are associated with poor kidney allograft survival. However, the effect of these alleles in living…
  • 2016 American Transplant Congress

    Urinary Neutrophil Gelatinase-Associated Lipocalin in Living Kidney Donor Nephrectomy.

    Y. Yoon,1 H. Lee,1 D. Joo,2 K. Huh,2 M. Kim,2 S. Kim,2 Y. Kim,2 W. Han.1

    1Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; 2Transplantation Surgery, Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.

    Introduction: Urinary neutrophil gelatinase-associated lipocalin (uNGAL) is a marker for acute kidney injury. This study was conducted to evaluate the efficacy of perioperative uNGAL in…
  • « Previous Page
  • 1
  • …
  • 447
  • 448
  • 449
  • 450
  • 451
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences